AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Aconride M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Aconwell Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Aconride M 1mg/500mg Tablet SR

Diabetic patients using the extended-release formulation, Aconride M (1mg/500mg), benefit from its dual-action anti-diabetic properties. This medication combines two active agents to manage type 2 diabetes in adults, effectively regulating blood glucose. Optimal results are achieved by taking Aconride M with meals, consistently at the same time daily, following your physician's prescribed dosage. This dosage may adjust over time, depending on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar and potential complications such as kidney impairment, vision loss, neuropathy, and limb amputation. Remember, Aconride M complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Lifestyle changes are integral to diabetes management. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Learn to recognize and treat hypoglycemia, maintaining regular mealtimes and carrying readily available glucose (e.g., sugary snacks or juice). Alcohol consumption intensifies the risk of hypoglycemia and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain is also possible. Aconride M is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac disease should consult their doctor before starting this medication. Similarly, pregnant or breastfeeding women require medical advice before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Aconride M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Aconride M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Aconride M 1mg/500mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Aconride M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Aconride M 1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Aconride M 1mg/500mg Sustained-Release tablets with food.

How Aconride M 1mg/500mg Tablet SR works:

Aconride M 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Aconride M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Aconride M 1mg/500mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Aconride M 1mg/500mg SR tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Aconride M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Aconride M 1mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Aconride M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Aconride M 1mg/500mg SR tablets are typically initiated at a reduced dosage for individuals with mild to moderate liver disease; however, their use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Aconride M 1mg/500mg Tablet SR :

Should you forget to take a dose of Aconride M 1mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Aconride M 1mg/500mg Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Aconride M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Aconride M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Aconride M 1mg/500mg Tablet SR and seek immediate medical attention.
Aconride M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Aconride M 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Aconride M 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Aconride M 1mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Aconride M 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Aconride M 1mg/500mg Tabl...
40
MRP 46
13% off